Novel method of administering meclizine type pharmaceutical agents and novel dosage forms containing same
Patent 4729997 Issued on March 8, 1988. Estimated Expiration Date: 
August 19, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 19, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod and preparation for administration to the mucosa of the oral or nasal cavity Patent #: 4250163 InventorAssigneeApplicationNo. 06/897863 filed on 08/19/1986US Classes:514/255.04, Plural carbocyclic rings bonded directly to the same acyclic carbon atom which is attached directly or indirectly to the piperazine ring by nonionic bonding514/226.2, Chalcogen or nitrogen attached indirectly to the phenothiazine ring nitrogen by acyclic nonionic bonding514/294, Ring nitrogen is shared by two of the cyclos514/307Isoquinolines (including hydrogenated)ExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassesA61K 9/00 (20060101)A61K 31/135 (20060101) A61K 31/165 (20060101) A61K 31/44 (20060101) A61K 31/47 (20060101) A61K 31/495 (20060101) A61K 31/54 (20060101) A61K 31/52 (20060101) A61K 31/55 (20060101) A61K 31/519 (20060101) AbstractInvention relates to nasal administration of known anti-nausea and anti-emetic therapeutic agents and dosage forms useful for such administration.Other References
| |
